Fatigue Countermeasure Program in Operational Flight Controllers
NCT ID: NCT01744678
Last Updated: 2019-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2012-09-30
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specifically, the investigators will:
1. Feasibility. Test the feasibility of developing a break room containing fatigue countermeasures (shorter-wavelength light and exercise equipment) to be used by flight mission controllers during Orbit 1 night shifts, and the feasibility to schedule regular breaks during the Orbit 1 shift so that flight mission controllers have the opportunity to use the fatigue countermeasures break room.
2. Acceptability. Test the acceptability of the use of the fatigue countermeasures break room evaluating when and how the room is used by flight mission controllers, as measured on End-of-Shift Productivity Questionnaire.
3. Test the hypothesis that alertness and performance will be impaired in flight mission controllers during Orbit 1 operational night shifts as compared to flight mission controllers working a non-console day shift.
4. Test the hypothesis that alertness and performance of flight mission controllers who exercise and are exposed to shorter wavelength light during the Orbit 1 night shift will be significantly more alert and have better mood, performance (e.g., less Psychomotor Vigilance Task (PVT) lapses, increased productivity) than those same mission controllers working Orbit 1 night shifts without exposure to the shorter wavelength light and exercise.
5. Test the acceptability, operational feasibility and efficacy of implementing an anonymous sleep disorders screening for flight controllers, evaluated by number of visitors to the screening web site and the number of completed assessments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatigue in Short-Haul Operations
NCT05524441
Effects of Light and Exercise on Human Circadian Rhythms and Performance
NCT02747719
Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control
NCT02755493
Operational Evaluation of a Photic Countermeasure to Improve Alertness, Performance, and Mood During Nightshift Work on a 105-day Simulated Human Exploration Mission to Mars
NCT01169233
Improving Night Shift Nurses' Health and Reducing Burnout
NCT06829979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Access to experimental break room
Subjects will visit the experimental break room 4 times per Orbit 1 shift:
* first, prior to the beginning of the work shift
* second, during an operationally feasible 20-min break during the 1st half of the work shift
* third, once during an operationally feasible 20-min break during the 2nd half of the work shift
* fourth, immediately after the end of the work shift
In the break room, subjects will be passively exposed to blue-wavelength enriched ceiling lights during all four visits for each work shift.
Also in the break room, subjects will perform 10-minutes of mild exercise during the first three visits to the break room during each work shift.
blue-wavelength enriched ceiling light
Subjects will be in the experimental break room for four 20-minute periods for each Orbit 1 work shift.
mild exercise
Subjects will be asked to achieve 65% of maximum heart rate on either a treadmill or exercise cycle for 10-minutes, three times during each Orbit 1 work shift.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blue-wavelength enriched ceiling light
Subjects will be in the experimental break room for four 20-minute periods for each Orbit 1 work shift.
mild exercise
Subjects will be asked to achieve 65% of maximum heart rate on either a treadmill or exercise cycle for 10-minutes, three times during each Orbit 1 work shift.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Work schedule must meet both study needs and National Aeronautics and Space Administration (NASA) scheduling operational constraints
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Aeronautics and Space Administration (NASA)
FED
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles Andrew Czeisler, MD, PhD
Chief, Division of Sleep Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles A Czeisler, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital / Harvard Medical School
Laura K Barger, PhD
Role: STUDY_DIRECTOR
Brigham and Women's Hospital / Harvard Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johnson Space Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NNX10AF47G
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.